Clinical Trial Update: The Pilot Clinical Study of PG2 Injection on Hemorrhagic Stroke [EARLY_Phase 1]

View source ↗

Summary

The early-phase, pilot trial of PG2 Injection for hemorrhagic stroke has completed, according to the sponsor update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Stroke

Drugs mentioned

• PG2 Injection (PG2)

Snippet

Sponsor: PhytoHealth Corporation | Conditions: Hemorrhagic Stroke | EARLY_Phase 1 | Status: COMPLETED